Anemia Clinical Trials

Find Anemia Clinical Trials Near You

EFFECTS of MORINGA OLEIFERA LEAF MICRONIZED POWDERS on HEMATOLOGICAL PROFILES, PERIPHERAL BLOOD SMEAR, HEPCIDIN, AND CYTOKINES (IL-1 DAN IL-6) OF PREGNANT WOMEN WITH IRON DEFICIENCY ANAEMIA

Status: Active_not_recruiting
Location: See location...
Intervention Type: Drug, Dietary supplement
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Title: The Effect of Moringa Oleifera Leaf Micronized Powders on Hematological Profile, Hepcidin, and Cytokines (IL-1 and IL-6) in Pregnant Women with Iron Deficiency Anemia Study Description: Iron deficiency anemia is one of the most common health problems affecting pregnant women worldwide, especially in developing countries like Indonesia. This condition can cause serious complications for both mothers and babies, such as premature birth, low birth weight, and increased risk of maternal mortality. Despite the availability of iron supplements as a standard treatment, many women experience side effects such as nausea, constipation, and poor absorption, which often lead to low adherence to the medication. This clinical study aims to explore the potential of Moringa Oleifera leaf micronized powders (finely ground Moringa leaf powder) as a natural, plant-based supplement to help improve hemoglobin levels in pregnant women suffering from iron deficiency anemia. Moringa leaves are known for their rich nutritional content, including iron, antioxidants, and anti-inflammatory compounds, making them a promising alternative to traditional iron supplements. The study will involve 72 pregnant women between 28-32 weeks of gestation diagnosed with iron deficiency anemia. Participants will be randomly assigned into two groups: Group A will receive Moringa leaf capsules along with standard iron tablets. Group B will receive only standard iron tablets as the control group. The intervention will last for 60 days, during which participants will undergo regular blood tests to measure hemoglobin levels, iron status markers (hepcidin, TIBC), and inflammatory cytokines (IL-1 and IL-6). The study will also monitor the safety of Moringa leaf supplements, including liver and kidney functions. Hypothesis: The study hypothesizes that adding Moringa Oleifera leaf micronized powders to standard iron therapy will significantly improve hemoglobin levels, iron status, and reduce inflammation in pregnant women with iron deficiency anemia compared to iron tablets alone. This research is expected to provide scientific evidence supporting the use of Moringa leaves as a safe, effective, and affordable alternative therapy to help combat iron deficiency anemia during pregnancy.

Eligibility
Participation Requirements
Sex: Female
Minimum Age: 18
Maximum Age: 44
Healthy Volunteers: f
View:

• Demographic Characteristics:

‣ Women aged 18-44 years

⁃ Married, have a husband and/or family

⁃ Have an ID card

• Clinical Characteristics:

‣ Pregnant with a gestational age of 28 to \<32 weeks

⁃ Live single fetus

⁃ Hemoglobin (Hb) 7 - \< 11 g/dl

⁃ No congenital abnormalities

⁃ No complication (DM, infection, genetic disease) based on history taking, clinical signs and symptoms and treatment history.

⁃ Parity \< 4

• Geographical/Administrative Characteristics:

‣ The study subjects (pregnant women) were located in the working area of the health facility where the study was conducted.

∙ Health Facility where the study was conducted.

∙ \- Come to the health facility independently or by referral.

Locations
Other Locations
Indonesia
Pusat Kesehatan Masyarakat (PUSKESMAS)
Cianjur
Time Frame
Start Date: 2025-05-23
Completion Date: 2026-05-31
Participants
Target number of participants: 59
Treatments
Experimental: Intervention Group - Moringa Oleifera Leaf Micronized Powders + Standard Iron Tablets
Participants in this group will receive Moringa Oleifera Leaf Micronized Powders (MOLMP) 3×650 mg/day in capsule form, combined with standard iron tablets (Fe tablet 60 mg + Folic Acid 400 mcg/day) for 60 days.~This intervention aims to evaluate the combined effect of Moringa Oleifera and standard iron supplements on hematological parameters, iron homeostasis, and inflammatory markers in pregnant women with iron deficiency anemia.
Active_comparator: Active Comparator: Control Group - Standard Iron Tablets Only
Participants in this group will receive only standard iron tablets (Fe tablet 60 mg + Folic Acid 400 mcg/day) for 60 days.~This arm serves as the control group to compare the effectiveness of standard iron therapy alone versus the combined intervention (MOLMP + Iron Tablets).
Sponsors
Leads: Universitas Padjadjaran

This content was sourced from clinicaltrials.gov